An NSF International Company Packaging Validation: E&L; Detection
Wednesday the 27th November 2013
Improve patient safety and avoid costly product-launch delays
By Kurt L. Moyer and James R. Scull, NSF Health Sciences
Well-documented incidents of contaminants leaching from containers and packaging has brought heightened awareness of the health risks posed by extractables and leachables in the manufacture of pharmaceutical container systems and product packaging. In fact, the FDA and the EMA are now placing increased scrutiny on potential extractables and leachables in drug product container and closure systems.
- Read more at: www.contractpharma.com
